Welcome to our dedicated page for Astrana Health SEC filings (Ticker: ASTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Astrana Health, Inc. (NASDAQ: ASTH), a physician-centric, AI-powered and technology-enabled healthcare company focused on value-based care and population health management. Through these filings, investors can review how Astrana reports its financial condition, segment performance, acquisitions, and other material events.
Astrana’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, describe the company’s three reportable segments—Care Partners, Care Delivery, and Care Enablement—and present detailed revenue and expense information. These filings also discuss topics such as medical liabilities, long-term debt, noncontrolling interests, and the structure of consolidated entities and variable interest entities.
Current reports on Form 8-K and amendments on Form 8-K/A document significant developments, including quarterly earnings announcements, updated investor presentations, and the completion and accounting treatment of acquisitions. For example, Astrana has filed 8-Ks and 8-K/As related to the closing of the Prospect Health acquisition, associated credit agreements, and the inclusion of audited financial statements and unaudited pro forma financial information for the acquired business.
Investors interested in transaction details, guidance updates, and capital structure changes can use these filings to understand how Astrana finances acquisitions, manages leverage, and integrates new entities into its operations. Regulation FD disclosures and furnished exhibits, such as earnings presentations and investor decks, offer additional context on the company’s strategy and performance.
Stock Titan’s tools surface Astrana Health’s latest SEC filings in near real time and apply AI-powered summaries to help explain the key points in lengthy documents. Users can quickly scan 10-K and 10-Q highlights, review 8-K event descriptions, and identify exhibits related to acquisitions, credit facilities, and pro forma financials. Form 4 insider transaction filings, when available, can also be accessed to see reported trading activity by company insiders.
By using this SEC filings page, readers gain a structured view of Astrana Health’s regulatory disclosures, from core financial statements to acquisition-related information and investor communications, supported by AI-generated insights that make complex filings easier to interpret.